QNBK:QSEQatar National Bank QPSC Analysis
Data as of 2026-05-21 - not real-time
QAR 17.20
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
QNBK is trading at QAR 17.2, comfortably below its 20‑day (≈17.56) and 50‑day (≈17.62) moving averages and well under the 200‑day level (≈18.63), signaling a short‑term bearish bias. The MACD is in a bearish crossover, RSI sits near 39, and volume is on a downtrend, placing the price close to the identified support at QAR 17.11 and far from the resistance near QAR 18.30. Technical momentum therefore suggests caution in the near term.
Fundamentally, the bank appears attractively priced: a trailing P/E of ~9.8 versus an industry average of ~16.7, a solid dividend yield of 4.21% with a modest 41% payout, 11% revenue growth, and a healthy profit margin of ~48%. Analyst consensus is a "strong buy" with a median target of QAR 21.45, implying upside potential of over 25% and indicating the stock is likely undervalued relative to its earnings and cash‑flow profile.
Fundamentally, the bank appears attractively priced: a trailing P/E of ~9.8 versus an industry average of ~16.7, a solid dividend yield of 4.21% with a modest 41% payout, 11% revenue growth, and a healthy profit margin of ~48%. Analyst consensus is a "strong buy" with a median target of QAR 21.45, implying upside potential of over 25% and indicating the stock is likely undervalued relative to its earnings and cash‑flow profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical indicators (price below SMAs, MACD bearish)
- Decreasing trading volume
- Proximity to short‑term support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation metrics (low P/E, attractive P/B)
- Strong dividend yield with sustainable payout
- Analyst consensus of strong buy and sizable upside target
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Stable earnings and high ROE
- Low beta indicating limited price volatility
- Strategic regional presence and diversified banking segments
Key Metrics & Analysis
Financial Health
Revenue Growth11.00%
Profit Margin47.79%
P/E Ratio9.8
ROE14.58%
ROA1.27%
P/B Ratio1.5
Op. Cash FlowQAR-69855158272
Industry P/E16.7
Technical Analysis
TrendBearish
RSI38.9
SupportQAR 17.11
ResistanceQAR 18.30
MA 20QAR 17.56
MA 50QAR 17.62
MA 200QAR 18.63
MACDBearish
VolumeDecreasing
Fear & Greed Index91.3
Valuation
Target PriceQAR 21.71
Upside/Downside26.19%
GradeUndervalued
TypeValue
Dividend Yield4.21%
Risk Assessment
Beta0.15
Volatility13.99%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.